EphrinB2 Expression in Urothelial Cancer Tied to Checkpoint Inhibitor Activity
A prior analysis of data from The Cancer Genome Atlas (TCGA) demonstrated that high EphrinB2 gene expression was associated with poor survival in patients with muscle-invasive bladder cancer. At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported new findings showing that EphrinB2 expression in patients with metastatic urothelial carcinoma was linked with […]